In this study, we investigate transcriptomic data across multiple breast tumour datasets using differential variability analysis to identify genes that are associated with BRCA1 and BRCA2 pathogenic variant status and with different tumour subtypes. This evidence concerns the gene BRCA2 and breast neoplasm.